/Investor DB

Noro-Moseley Partners — 2026 Investments

4 investments dated 2026 · listed companies and verified rows first · show all

Avoavonow.comApr 2026 · $125MDefunct

Avo operates a marketplace within residential and office buildings that delivers groceries, cleaning services, and other goods to tenants, with building operators handling customer acquisition.

ConsumerE-commerceTel Aviv-Yafo, IL

Dekel Valtzer(CEO)inIdan Hershko(Founder)inNir Smadar(CTO)

Co-investorsInsight PartnersY CombinatorAlleyCorpDunamu & PartnersF2 Venture CapitalFeldsmith Capital+12 more

Avoavo.appin𝕏Apr 2026 · $125M

Avo is a SaaS analytics governance platform that helps product managers, developers, and data scientists plan, track, and govern product analytics.

Data & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSReykjavík, IS

Stefania Olafsdottir(CEO)inSölvi Logason(Co-Founder / Product & CTO)inArni Hermann Reynisson(Founder)Dekel Valtzer(Founder)inIdan Hershko(Founder)inNir Smadar(Founder)

Co-investorsHeavybitNotable CapitalY CombinatorBackbone AngelsBrunnur Ventures GPCrowberry Capital+11 more

Avoavo.so𝕏Apr 2026 · $125M

Avo is a DeFi platform that enables capital allocation through AI trading agents and curated smart indexes, allowing users to allocate funds based on narratives and strategies on Solana.

AI & Machine LearningCrypto & Web3Fintech

Co-investorsAntlerFront Row VenturesAlleyCorpDunamu & PartnersFuturePlayInsight Partners+4 more

AvoMDavomd.comin𝕏Apr 2026 · $125M

Avo is a clinical artificial intelligence platform designed to reduce clinician burnout and improve healthcare outcomes by helping doctors practice evidence-based medicine.

AI & Machine LearningDigital HealthHealthtechBrooklyn, US

Joongheum Park(Founder / Executive Chairman / CPO)inYair Saperstein(Founder / CEO)inLaurence Coman(Founder / COO)in

BoardOmar Njie(Director)

Co-investors500 GlobalAlleyCorpDunamu & PartnersEpsilon Health InvestorsLas Olas Venture CapitalMana Ventures+9 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.